Cargando…
Tumor-Targeting Ability of Novel Anti-Prostate-Specific Membrane Antigen Antibodies
[Image: see text] Patients with prostate-specific membrane antigen (PSMA)-positive tumors can benefit from PSMA-targeted therapy; thus, we have constructed a phage-displayed synthetic antibody library for the production of novel PSMA antibodies with superior PSMA-targeting ability, favoring clinical...
Autores principales: | Hsieh, Hsin-Hua, Kuo, Wei-Ying, Lin, Jia-Jia, Chen, Hong-Sen, Hsu, Hung-Ju, Wu, Chun-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454275/ https://www.ncbi.nlm.nih.gov/pubmed/36092556 http://dx.doi.org/10.1021/acsomega.2c04230 |
Ejemplares similares
-
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017) -
Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model
por: Kuo, Wei-Ying, et al.
Publicado: (2018) -
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
por: Chen, Yang, et al.
Publicado: (2022) -
Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010) -
Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)